Healthcare Equipment and Supplies
Company Overview of Myocor, Inc.
As of October 31, 2008, Myocor, Inc. was acquired by Edwards Lifesciences Corp. Myocor, Inc., a clinical stage medical device company, engages in developing less invasive therapeutic options for the treatment of mitral regurgitation and heart failure. It offers Coapsys, a device that allows for a less invasive closed heart surgical treatment option for FMR and LV dysfunction; and iCoapsys, which offers a closed chest, catheter-based, and less invasive interventional treatment option for FMR and LV dysfunction. The company was founded in 1996 and is based in Maple Grove, Minnesota.
13300 67th Avenue North
Maple Grove, MN 55311-3529
Founded in 1996
Key Executives for Myocor, Inc.
Myocor, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Myocor, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.